(Reuters) – The U.S. Food and Drug Administration on Friday approved Abbvie Inc’s oral treatment for managing heavy menstrual bleeding associated with fibroids in premenopausal women. The treatment is the first non-surgical option available to patients …
See Original Article

Farmers markets are allowed to offer in-person sales, but pre-orders and deliveries are encouraged when available. By Emily Leayman, Patch Staff. May 29, 2020 3:54 pm ET. Reply. 0. Four Alexandria farmers markets can resume in-person purchases as …
See Original Article

Update, 5/29/20: Earlier this week, Nissan released a video previewing all the new and refreshed vehicles coming to its showrooms. The all-new Z was the main attraction, but the first vehicle to be glimpsed was what appeared to be the much-anticipated …
See Original Article

Xero's cloud-based accounting and practice management platform offers the unique financial management tools and real-time insights that can boost
See Original Article

Most of the recent enthusiasm around AbbVie’s new drugs has centered on immunology meds Skyrizi and Rinvoq, but women’s health med elagolix—known commercially as Orilissa in endometriosis—wants a piece of the spotlight, too. The therapy Friday …
See Original Article